| 1 |
Gatwiri W, Kagia R. Identification of potential compounds for the management of multidrug-resistant tuberculosis using computational methods. F1000Res 2023;12:298. [DOI: 10.12688/f1000research.130024.1] [Reference Citation Analysis]
|
| 2 |
Parsa S, Yaghoubi A, Izadi N, Sabet F, Nik LB, Derakhshan M, Rezaee SA, Meshkat Z, Hoseini SJ, Jmehdar SA, Kiani F, Samiei A, Soleimanpour S. Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates from Sputum Samples by High-Resolution Melting Analysis. Curr Microbiol 2022;79:257. [PMID: 35852629 DOI: 10.1007/s00284-022-02960-z] [Reference Citation Analysis]
|
| 3 |
Bagheri Z, Yaghoubi A, Sabet F, Meshkat Z, Ghazvini K, Rezaee SA, Aryan E, Soleimanpour S, Shamsian SA. Inconsistency of QuantiFERON-TB Gold Test and Tuberculin Skin Test Results in the Evaluation of Latent Tuberculosis Infection in Health Care Workers. Mol Genet Microbiol Virol 2021;36:204-209. [DOI: 10.3103/s0891416821040030] [Reference Citation Analysis]
|
| 4 |
Randera-rees S, Clarence Safari W, Gareta D, Herbst K, Baisley K, Grant AD. Can we find the missing men in clinics? Clinic attendance by sex and HIV status in rural South Africa. Wellcome Open Res 2021;6:169. [DOI: 10.12688/wellcomeopenres.16702.1] [Reference Citation Analysis]
|
| 5 |
Mumena D, Kwenda G, Ngugi C, Nyerere A. Molecular Detection of Drug-Resistant Mycobacterium tuberculosis in Sputum Specimens from the New and Previously Treated Tuberculosis Cases at the National Reference Chest Diseases Laboratory in Lusaka, Zambia. J Biomed Res Environ Sci 2021;2:232-243. [DOI: 10.37871/jbres1218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Makori L, Gichana H, Oyugi E, Nyale G, Ransom J. Tuberculosis in an urban hospital setting: Descriptive epidemiology among patients at Kenyatta National Hospital TB clinic, Nairobi, Kenya. International Journal of Africa Nursing Sciences 2021;15:100308. [DOI: 10.1016/j.ijans.2021.100308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Zhang L, Xing W, Zhou J, Zhang R, Cheng Y, Li J, Wang G, Liu S, Li Y. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study. BMC Infect Dis 2020;20:576. [PMID: 32758169 DOI: 10.1186/s12879-020-05304-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Sinshaw W, Kebede A, Bitew A, Tesfaye E, Tadesse M, Mehamed Z, Yenew B, Amare M, Dagne B, Diriba G, Alemu A, Getahun M, Fikadu D, Desta K, Tola HH. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia. BMC Infect Dis 2019;19:641. [PMID: 31324227 DOI: 10.1186/s12879-019-4241-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 9 |
Alelign A, Zewude A, Mohammed T, Tolosa S, Ameni G, Petros B. Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia. BMC Infect Dis 2019;19:343. [PMID: 31023267 DOI: 10.1186/s12879-019-3978-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 10 |
Ogari CO, Nyamache AK, Nonoh J, Amukoye E. Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya. BMC Infect Dis 2019;19:279. [PMID: 30909867 DOI: 10.1186/s12879-019-3911-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 11 |
Sirous M, Khosravi AD, Tabandeh MR, Salmanzadeh S, Ahmadkhosravi N, Amini S. Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis. Infect Drug Resist 2018;11:1819-29. [PMID: 30425535 DOI: 10.2147/IDR.S178831] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 12 |
Reuter A, Furin J. Optimal Management of Drug-Resistant Tuberculosis and Human Immunodeficiency Virus: an Update. Curr Treat Options Infect Dis 2018;10:90-106. [DOI: 10.1007/s40506-018-0145-0] [Reference Citation Analysis]
|
